DiaCarta Annual Revenue, Number of Employees, Growth and Funding
Navigation
Overview
Industry Ranking
State Ranking
Estimated Revenue & Financials
- DiaCarta's estimated annual revenue is currently $6.2M per year.
- DiaCarta received $45.0M in venture funding in February 2018.
- DiaCarta's estimated revenue per employee is $144,186
- DiaCarta's total funding is $53M.
Employee Data
- DiaCarta has 43 Employees.
- DiaCarta grew their employee count by 10% last year.
- DiaCarta currently has 1 job openings.
Executive Contacts
| Name | Title |
|---|---|
| Elena Peletskaya | Director, Molecular Analytics, Juno Therapeutics |
| Aiguo Zhang | Founder, President & CEO |
| Michael Powell | Chief Scientific Officer |
| Nitin Udar | Sr VP Diagnostics and Regulatory |
| Robyn Schlicher | Senior Director of Sales |
| Ke Zhan | Director, NGS |
What Is DiaCarta?
DiaCarta is a translational genomics and personalized diagnostics company that provides ultra-sensitive detection tools for cancer diagnosis, therapy identification and prognosis monitoring. Our mission is to provide ultra-sensitive and advanced technologies that will redefine the way molecular diagnostics and translational genomics impact healthcare treatment plans and the well-being of individuals around the world. To learn more, visit http://www.diacarta.com.
keywords:Biotechnology,Healthcare,Medical Diagnostics,Pharmaceuticals43
Number of Employees
$6.2M
Revenue (est)
1
Current Jobs
10%
Employee Growth %
$53M
Total Funding
N/A
Valuation
N/A
Accelerator
B2B
Type
Similar Companies
| Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
| $6.2M | 43 | 10% | N/A | |
| $10.7M | 74 | 45% | N/A | |
| $42M | 290 | 4% | N/A | |
| $26.4M | 182 | 3% | N/A | |
| $5.9M | 41 | 37% | N/A | |
| $25.7M | 178 | 8% | N/A | |
| $5.7M | 40 | 11% | N/A | |
| $4.2M | 33 | -15% | N/A | |
| $6M | 42 | 5% | N/A | |
| $7.1M | 49 | -2% | N/A |
DiaCarta News
BUSINESS WIRE)--DIACARTA, Inc., a precision diagnostic company and leading developer of products for nucleic acid-based detection ...
RICHMOND, Calif.--(BUSINESS WIRE)--DiaCarta today announced that CIO Bulletin has named it among the 30 Fastest Growing Companies ...
NEW YORK (GenomeWeb) – DiaCarta said today that it has completed a Series B funding round, raising a total of $45 million. The second ...
DiaCarta Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2015-01-12 | $8.0M | A | BVCF | Article |
| 2018-02-13 | $45.0M | B | Fortune Fountain Capital | Article |